Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, September 8, 2016

Top scientists lay out sweeping recommendations for ‘moonshot’ against cancer

Where is the sweeping recommendations for the stroke moonshot? We have none but we do have fucking failures of stroke associations to comfort us instead.
Mine are here:
Address the complete problems in stroke.
 And here:
These 177 hyperacute therapies that need more research.
And here:
My 31 ideas on hyperacute therapy I'm going to insist my doctor give me during the first week.
And here: 
To test out these 17 diagnosis possibilities to find out which one is the best? Or maybe the Qualcomm Xprize for the tricorder? 
And here: 
Solve the neuronal cascade of death by these 5 causes in the first week. 
https://www.statnews.com/2016/09/07/cancer-research-moonshot-panel-report/
A panel of top scientists is urging the Obama administration to bet big on tumor profiling and immunotherapy treatments in its cancer moonshot — two areas that are viewed with great promise, but still face unanswered questions about their ultimate effectiveness.
The experts are recommending the creation of a new national network that would allow cancer patients across the country to have their tumors genetically profiled and included in a new national database — one of several recommended steps that they say would significantly speed the progress of cancer research in the United States.
The panel is also urging the creation of a network to coordinate clinical trials using immunotherapy, the promising new treatment that turns the body’s immune system against the disease.
article continues after advertisement
Sponsor Content
The physician-scientist: Travis Hinson’s journey to a better heart
Mixing numerous chemicals just wasn’t enough for Travis Hinson. “I wanted to do science that made a difference in people’s health.” For Hinson, that difference is with the heart.
Sponsor Content by The Jackson Laboratory
The recommendations are part of a report issued Wednesday by an expert panel advising the White House in its cancer moonshot initiative. It was formally accepted by the National Cancer Advisory Board Wednesday morning.
The tumor network would help scientists better identify which treatments work for which cancers in which patients, the panel said. As scientists become more aware of the many different kinds of cancer, and turn increasingly to more personalized treatments, they see the profiling the genetics of individual tumors as crucial.
Patients would be connected with the hospitals and cohorts across the country that profile tumors and those institutions would share the collected data. The network would both aid in enrolling specific patients in clinical trials that show promise for their cancer by letting them “pre-register” for trials, the panel said, and allow researchers to make broader observations about the genetic makeup of different cancers and about which treatments are successful in fighting them.

No comments:

Post a Comment